• Molecular NameChloroprocaine
  • SynonymChloroprocain; Chloroprocaine hydrochloride; Chlorprocaine
  • Weight270.76
  • Drugbank_IDDB01161
  • ACS_NO133-16-4
  • Show 3D model
  • LogP (experiment)2.86
  • LogP (predicted, AB/LogP v2.0)2.71
  • pkaN/A
  • LogD (pH=7, predicted)0.91
  • Solubility (experiment)0.665 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)-0.8
  • LogSw (predicted, AB/LogsW2.0)0.86
  • Sw (mg/ml) (predicted, ACD/Labs)0.36
  • No.of HBond Donors2
  • No.of HBond Acceptors4
  • No.of Rotatable Bonds7
  • TPSA55.56
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA local anesthetic given by injection during surgical procedures and labor and delivery.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmRapidly hydrolysed in the plasma to 4-amino-2-chlorobenzoic acid and 2-diethylaminoethanol.
  • Half life21 seconds
  • ExcretionAbout 50% of an intravenous dose is excreted in the urine in 90 min, mainly as an unidentified conjugate (possibly the glycine conjugate) of 4-amino-2-chlorobenzoic acid.
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityThe maximum safe intravenous or topical dose is 750 mg.
  • LD50 (rat)N/A
  • LD50 (mouse)N/A